GlassScriptPhysician profile
Jan Hronek
NPI 1447344668
$3,644.55
in general payments reported to CMS, 2019-2025
18 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,233 · 2022: $564 · 2023: $899 · 2024: $579 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,748.03 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adc Therapeutics America, INC. | $584.39 | 2021-2023 | |
| Incyte Corporation | $458.71 | 2021-2025 | Niktimvo, Jakafi, Monjuvi |
| Astrazeneca Pharmaceuticals LP | $349.30 | 2021-2024 | |
| Blueprint Medicines Corporation | $256.25 | 2022-2023 | Ayvakit |
| Janssen Biotech, INC. | $241.01 | 2022-2024 | Darzalex, Tecvayli |
| Seagen INC. | $239.29 | 2021-2023 | Tukysa |
| Rigel Pharmaceuticals, INC. | $229.57 | 2023-2024 | Tavalisse, Rezlidhia |
| Glaxosmithkline, LLC. | $123.59 | 2021 | |
| Genmab U.S., INC. | $122.51 | 2025 | Epkinly |
| Exelixis INC. | $121.94 | 2025 | Cabometyx |
| Emd Serono, INC. | $121.83 | 2024 | |
| Genzyme Corporation | $120.19 | 2021 | |
| Puma Biotechnology, INC. | $117.88 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $115.14 | 2023 | Libtayo |
| Gilead Sciences, INC. | $113.89 | 2023 | Trodelvy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stemline Therapeutics INC. | $111.95 | 2023 | Orserdu |
| Kite Pharma, INC. | $108.65 | 2022 | |
| Beigene USA, INC. | $108.46 | 2023 | Brukinsa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Hronek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.